Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Fluorescence in Situ Hybridization
100%
ThinPrep
100%
Anaplastic Lymphoma Kinase
100%
Immunohistochemistry
30%
Paraffin-embedded Tissue
20%
Anaplastic Lymphoma Kinase Rearrangement
20%
Truncation
10%
Two-sample
10%
Molecular Diagnostics
10%
Signal Amplification
10%
Targeted Therapy
10%
Cytological Samples
10%
Liquid-like
10%
Paraffin
10%
Limited Samples
10%
Companion Diagnostics
10%
Fine-needle Aspiration
10%
Two-color
10%
Ultrasensitive
10%
Tumor Area
10%
Tissue Fluorescence
10%
Crizotinib
10%
Cytological Diagnosis
10%
ALK Inhibitor
10%
Advanced Non-small Cell Lung Carcinoma
10%
Liquid-based Cytology
10%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Fluorescence in Situ Hybridization
100%
Cytotechnology
100%
Anaplastic Lymphoma Kinase
100%
Immunohistochemistry
27%
Gene Rearrangement
18%
Neoplasm
9%
Diagnosis
9%
Targeted Therapy
9%
Fine-Needle Aspiration
9%
Cytodiagnosis
9%
ALK Inhibitor
9%
Crizotinib
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Anaplastic Lymphoma Kinase
100%
Neoplasm
9%
Crizotinib
9%
Anaplastic Lymphoma Kinase Inhibitor
9%
Biochemistry, Genetics and Molecular Biology
Fluorescence in Situ Hybridization
100%
Gene Rearrangement
16%
Crizotinib
8%